Since the neuropathological changes of progressive memory loss and cognitive deficit have been linked to oxidative damage and cholinergic dysfunction [2, 3], free radical scavengers and acetylcholinesterase (AChE) inhibitors have been commonly used to treat these conditions. This evidence concerns the gene ACHE and Cognitive impairment.